Comorbid diabetes and copd: Impact of corticosteroid use on diabetes complications

Diabetes Care

Volumn 36, Issue 10, 2013, Pages 3009-3014

  Caughey, Gillian E ^a   Preiss, Adrian K ^a   Vitry, Agnes I ^a   Gilbert, Andrew L ^a   Roughead, Elizabeth E ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IPRATROPIUM BROMIDE; METFORMIN; SULFONYLUREA DERIVATIVE; TIOTROPIUM BROMIDE;

AGED; ARTHROPATHY; ARTICLE; AUSTRALIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC ARTHROPATHY; DIABETIC COMA; DIABETIC HYPEROSMOLALITY; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; HOSPITALIZATION; HUMAN; HYPEROSMOLALITY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

EID: 84891848318     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2197     Document Type: Article

References (30)

1. Kerr EA,Heisler M, Krein SL, et al. Beyond comorbidity counts: how do comorbidity type and severity influence diabetes patients' treatment priorities and selfmanagement? J Gen Intern Med 2007;22: 1635-1640
2. Caughey GE, Roughead EE, Vitry AI, McDermott RA, Shakib S, Gilbert AL. Comorbidity in the elderly with diabetes: identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 2010;87:385-393
3. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006;29:725-731
4. Fortin M, Soubhi H, Hudon C, Bayliss EA, van den Akker M. Multimorbidity's many challenges. BMJ 2007;334:1016-1017
5. Rabe KF, Wedzicha JA. Controversies in treatment of chronic obstructive pulmonary disease. Lancet 2011;378:1038-1047
6. Grant RW, Wexler DJ, Ashburner JM, Hong CS, Atlas SJ. Characteristics of "complex" patients with type 2 diabetes mellitus according to their primary care physicians. Arch Intern Med 2012;172: 821-823
7. McKenzie DK, Abramson M, Crockett AJ, et al.; on behalf of The Australian Lung Foundation. The COPD-X Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease v2.30. Brisbane, Australian Lung Foundation, 2011
8. Rabe KF, Hurd S, Anzueto A, et al.; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. AmJ Respir Crit Care Med 2007;176:532-555
9. The NHMRC and the Diabetes Australia Guideline Development Consortium. National evidence based guidelines for the management of type 2 diabetes mellitus [Internet]. Available from http://www .nhmrc.gov.au/publications/ synopses/ di7todi13syn.htm. Accessed 12 December 2011
10. Slatore CG, Bryson CL, Au DH. The association of inhaled corticosteroid use with serum glucose concentration in a large cohort. Am J Med 2009;122:472-478
11. Suissa S, Kezouh A, Ernst P. Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med 2010;123: 1001-1006
12. Australian Government Department of Veterans' Affairs. Treatment population statistics, quarterly report June 2010 [Internet]. Available from .gov.au/aboutDVA/Statistics/Documents/ TpopJun10.pdf. Accessed June 6th 2011
13. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical code classification indexwith defined daily doses [Internet]. Available from http://www .Whocc.No/atcddd. Accessed 25 June 2010
14. Australian Government Department of Health and Ageing. Schedule of pharmaceutical benefits. PBS for health professionals. 2010. Available from http://www .pbs.gov.au/html/healthpro/home. Accessed 1 July 2011
15. World Health Organization International Classification of Diseases. International statistical classification of diseases and related health problems 10th revision. Geneva, World Health Org., 2007
16. Diabetes Australia, Royal Australian College for General Practitioners. Diabetes Management in General Practice. Guidelines for Type 2 Diabetes. 16th ed. Canberra, Diabetes Australia, 2010
17. World Health Organization Collaborating Centre for Drug Statistics Methodology. Defined daily dose: definition and general considerations [Internet]. Available from http:// www.Whocc.No/ddd/definition-and-general- considera/. Accessed 25 June 2011
18. Mash BRJ, Bheekie A, Jones PW. Inhaled vs oral steroids for adults with chronic asthma. Cochrane Database Syst Rev 2001; (1):CD002160
19. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of competing risks in survival analysis. J Am Stat Assoc 1999;94:496-509
20. Australian Bureau of Statistics (ABS). Information Paper: Census of Population and Housing - Socioeconomic Indexes for Areas, Australia, 2001. Canberra, Australia, ABS, 2003
21. Vitry AI,Wong SA, Roughead EE, Ramsay E, Barratt J. Validity of medication-based co-morbidity indices in the Australian elderly population. Aust N Z J Public Health 2009;33:126-130
22. Szychowski JM, Roth DL, Clay OJ, Mittelman MS. Patient death as a censoring event or competing risk event in models of nursing home placement. Stat Med 2010;29:371-381
23. BoydCM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005;294:716-724
24. Suissa S, Barnes PJ. Inhaled corticosteroids in COPD: the case against. Eur Respir J 2009;34:13-16
25. Blackburn D, Hux J, Mamdani M. Quantification of the risk of corticosteroidinduced diabetes mellitus among the elderly. J Gen Intern Med 2002;17:717-720
26. Ferris HA, Kahn CR. New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it. J Clin Invest 2012;122:3854-3857
27. Rana JS, Mittleman MA, Sheikh J, et al. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004;27:2478-2484
28. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008;32: 962-969
29. Ta M, George J. Management of chronic obstructive pulmonary disease in Australia after the publication of national guidelines. Intern Med J 2011;41:263-270
30. Australian Institute of Health andWelfare (AIHW). Health Care Usage and Costs. A Comparison of Veterans and War Widows and Widowers with the Rest of the Community. Canberra, AIHW, 2002 (Cat. no. Phe42)